RankAlpha logo

SUJA

AI MemoPost-earnings T+1

Suja Life

As of 2026-11-11/Post-earnings T+1/Confidence medium
Data freshness
AI Memo
As of 2026-11-11 • Model: RankAlpha Sentiment Codex

Decision Panel

Action, confidence, horizon, and decision blockers at a glance.

Action
—
Confidence
medium
Horizon
—
Key catalyst
Reduced 2026 outlook tests fourth-quarter execution • 2026-12-28
Base target: $9 / p=45% prob
Biggest risk
Sales growth slowed to 3.3%, gross margin contracted 240 basis points, and both sales and adjusted EBITDA guidance were reduced. Goldman Sachs reportedly downgraded the shares to Neutral with a $12 target and cut its 2026 and 2027 adjusted EBITDA estimates to $69 million and $72 million, respectively; this is secondary reporting, not a company disclosure. https://ng.investing.com/news/stock-market-news/suja-life-stock-rating-cut-to-neutral-by-goldman-on-weak-results-93CH-2799876 [#SEC-8K-2026-11-10]
Invalidation
Break below $7 or thesis failure.
What would change my mind?
Q3 adjusted EBITDA rose to $10.5 million from about $1.0 million, supported by SG&A leverage, while volume gains and new distribution contributed to sales growth. Sustained channel gains and less promotional pressure could support recovery. [#SEC-8K-2026-11-10]
Research note
Recommendation
—
Confidence
medium
As of
2026-11-11
Base target
$9
p=45%
Bull target
$14
p=20%
Bear target
$7
p=35%

Key bullets

Fast scan of bull, bear, and watch items

BullKey bullets
  • Post-earnings repricing
  • Channel growth and margin recovery
  • Q3 adjusted EBITDA rose to $10.5 million from about $1.0 million, supported by SG&A leverage, while volume gains and new distribution contributed to sales growth.
BearKey bullets
  • Approximately $2 million of Q3 sales came from shipments previously expected in Q4, complicating the interpretation of quarterly growth.
  • [#SEC-8K-2026-11-10]
  • At September 28, cash was $15.5 million against $163.0 million of total debt; refinancing lowered the borrowing spread but did not eliminate leverage.
WatchKey bullets
  • Reduced 2026 outlook tests fourth-quarter execution

Summary

High-level snapshot

Recommendation
-
Model confidence
medium
Timeframe
-
Asset
Equity
Trigger
Post-earnings T+1
Base case: $9 (p=45%)
Target spread vs base: +56% / -28%
Scenario probabilities
Bull Target: $14 (p=20%)Base Target: $9 (p=45%)Bear Target: $7 (p=35%)
Commentary
Initial reaction was negative: Benzinga reported an 18.46% after-hours decline to $8.13 versus the $9.97 regular-session close, attributing it to softer outlook and a wider-than-expected adjusted loss per share despite revenue above its cited estimate. These are preliminary after-hours prices, not a confirmed November 11 close. A post-print Goldman downgrade is reported, but broader analyst revisions are not established. Social, options, short-interest and employee sentiment have not been verified; zeroes in those fields denote unavailable data, not neutral readings. https://www.benzinga.com/markets/equities/26/11/63130596/suja-life-suja-shares-fall-18-after-hours-heres-why
As of 2026-11-11 • Updated bi-weekly / post-earningsSource: Internal modelMethodology

Analyst Summary

Thesis highlights from the latest analysis

Bull Case
Q3 adjusted EBITDA rose to $10.5 million from about $1.0 million, supported by SG&A leverage, while volume gains and new distribution contributed to sales growth. Sustained channel gains and less promotional pressure could support recovery. [#SEC-8K-2026-11-10]
Bear Case
Sales growth slowed to 3.3%, gross margin contracted 240 basis points, and both sales and adjusted EBITDA guidance were reduced. Goldman Sachs reportedly downgraded the shares to Neutral with a $12 target and cut its 2026 and 2027 adjusted EBITDA estimates to $69 million and $72 million, respectively; this is secondary reporting, not a company disclosure. https://ng.investing.com/news/stock-market-news/suja-life-stock-rating-cut-to-neutral-by-goldman-on-weak-results-93CH-2799876 [#SEC-8K-2026-11-10]

Drivers

Scannable catalysts and supporting factors

  • Post-earnings repricing
  • Channel growth and margin recovery

Scenarios

Bull Target (Scenario probability)
$14 / p=20% prob
Base Target (Scenario probability)
$9 / p=45% prob
Bear Target (Scenario probability)
$7 / p=35% prob
Analysis 2026-11-11 · RankAlpha Sentiment Codex
Analysis reference price unavailable. Targets are shown without scenario returns.

Sentiment & Exposure

News Sentiment (30d)
-0.45
Social Sentiment (7d)
0.00

Events

Other notable items detected

  • EVENT2026-12-28
    Reduced 2026 outlook tests fourth-quarter execution
    Suja cut full-year sales guidance to $351–354 million from August's $360–369 million and adjusted EBITDA guidance to $68–70 million from $70–72 million. Management cited grocery softness; Q3 also included about $2 million of shipments previously expected in Q4. The new outlook implies Q4 sales of $83.7–86.7 million. [#SEC-8K-2026-11-10] [#SEC-8K-2026-08-04]
    Prob 60.00% • Move -8.00% • Priced-in 55.00%

Short-term Catalysts

Next few weeks

  • Post-earnings repricing
    2026-11-11
    Shares fell 18.46% to $8.13 in November 10 after-hours trading after a mixed Q3 report and lower full-year outlook. The $9.97 analysis anchor predates that reaction; whether the decline persists in regular trading is unconfirmed. Q3 sales were $76.4 million, but gross margin fell to 43.9% from 46.3%. [#SEC-8K-2026-11-10] [#8-K-2026-11-10]
    Prob 70% • Move -12% • Priced-in 50%

Long-term Catalysts

Months to a year

  • Channel growth and margin recovery
    2027-06-30
    A longer-term upside case requires new distribution and Refreshers and wellness-shot multipacks to offset softer single-serve shots, slower Emerging Brands distribution, promotional spending and freight and packaging costs. The Q3 release documents these opposing drivers but does not establish when gross margin will recover. [#SEC-8K-2026-11-10]
    Prob 35% • Move 20% • Priced-in 25%

Risks

  • Approximately $2 million of Q3 sales came from shipments previously expected in Q4, complicating the interpretation of quarterly growth. [#SEC-8K-2026-11-10]
  • At September 28, cash was $15.5 million against $163.0 million of total debt; refinancing lowered the borrowing spread but did not eliminate leverage. [#SEC-8K-2026-11-10]
  • Continued grocery-channel softness prompted a reduction in 2026 guidance. [#SEC-8K-2026-11-10]
  • Emerging Brands distribution built more slowly than expected, and softer single-serve shots partially offset core-brand growth. [#SEC-8K-2026-11-10]
  • Higher promotions, lower fixed-cost absorption, and inbound freight and packaging costs compressed Q3 gross margin. [#SEC-8K-2026-11-10]

Peers

SymbolSummary
LWAYClosest supplied beverage-oriented comparison, but product mix and economics differ; no verified trading-multiple comparison is available.
VITLSupplied better-for-you food-sector candidate, not a direct juice or wellness-shot peer; unsuitable as a stand-alone valuation anchor.

Sources

Internal and external references used in this analysis

  • Model source: RankAlpha Sentiment Codex
  • Analysis date: 2026-11-11